Literature DB >> 25239399

The role of tight junctions in cancer metastasis.

Tracey A Martin1.   

Abstract

Over the last decade, it has become apparent that the tight junction (TJ) is a key component in tumour progression and metastasis. In addition to its role in the control of paracellular diffusion of ions and certain molecules, the TJ has a vital role in maintaining cell to cell adhesion and tissue integrity. Changes in the expression and/or distribution of TJ proteins can result in loss in cohesion of the TJ structure, which in turn results in the ability of cancer cells to become invasive and then ultimately lead to the metastasis of cancer cells. This review will discuss recent insights into how TJ are involved in the process of tumour metastasis.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Metastasis; Tight junction; Tumour

Mesh:

Year:  2014        PMID: 25239399     DOI: 10.1016/j.semcdb.2014.09.008

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  47 in total

Review 1.  Roles of Grainyhead-like transcription factors in cancer.

Authors:  S M Frisch; J C Farris; P M Pifer
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

Review 2.  Loss of E-Cadherin-Dependent Cell-Cell Adhesion and the Development and Progression of Cancer.

Authors:  Heather C Bruner; Patrick W B Derksen
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-03-01       Impact factor: 10.005

3.  In focus in HCB.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2020-01       Impact factor: 4.304

4.  Effect of bevacizumab on the tight junction proteins of vascular endothelial cells.

Authors:  Yanan Jia; Tingting Qin; Xiaoling Zhang; Shaochuan Liu; Zhujun Liu; Cuicui Zhang; Jing Wang; Kai Li
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

Review 5.  Use of porous membranes in tissue barrier and co-culture models.

Authors:  Henry H Chung; Marcela Mireles; Bradley J Kwarta; Thomas R Gaborski
Journal:  Lab Chip       Date:  2018-06-12       Impact factor: 6.799

6.  Protein interactions of cortactin in relation to invadopodia formation in metastatic renal clear cell carcinoma.

Authors:  Hong-Liang Shen; Qing-Jun Liu; Pei-Qian Yang; Ye Tian
Journal:  Tumour Biol       Date:  2014-12-21

7.  Downregulation of lipolysis-stimulated lipoprotein receptor promotes cell invasion via claudin-1-mediated matrix metalloproteinases in human endometrial cancer.

Authors:  Hiroshi Shimada; Seiro Satohisa; Takayuki Kohno; Takumi Konno; Ken-Ichi Takano; Syunta Takahashi; Tsubasa Hatakeyama; Chihiro Arimoto; Tsuyoshi Saito; Takashi Kojima
Journal:  Oncol Lett       Date:  2017-09-22       Impact factor: 2.967

8.  ZIP4 Promotes Pancreatic Cancer Progression by Repressing ZO-1 and Claudin-1 through a ZEB1-Dependent Transcriptional Mechanism.

Authors:  Mingyang Liu; Jingxuan Yang; Yuqing Zhang; Zhijun Zhou; Xiaobo Cui; Liyang Zhang; Kar-Ming Fung; Wei Zheng; Felicia D Allard; Eric U Yee; Kai Ding; Huanwen Wu; Zhiyong Liang; Lei Zheng; Martin E Fernandez-Zapico; Yi-Ping Li; Michael S Bronze; Katherine T Morris; Russell G Postier; Courtney W Houchen; Jing Yang; Min Li
Journal:  Clin Cancer Res       Date:  2018-04-03       Impact factor: 12.531

9.  Low junctional adhesion molecule-A expression is associated with an epithelial to mesenchymal transition and poorer outcomes in high-grade serous carcinoma of uterine adnexa.

Authors:  Laudine Communal; Mauricio Medrano; Fabrice Sircoulomb; Joshua Paterson; Martin Köbel; Kurosh Rahimi; Paul Hoskins; Dongsheng Tu; Stephanie Lheureux; Amit Oza; Laurie Ailles; Diane Provencher; Robert Rottapel; Anne-Marie Mes-Masson
Journal:  Mod Pathol       Date:  2020-06-08       Impact factor: 7.842

10.  Up-regulated CKS2 promotes tumor progression and predicts a poor prognosis in human colorectal cancer.

Authors:  Min-Hao Yu; Yang Luo; Shao-Lan Qin; Zheng-Shi Wang; Yi-Fei Mu; Ming Zhong
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.